组织型纤溶酶原激活剂（tPA）在疑似中风和神经影像学检查阴性的脑缺血中的安全性：迅速给药还是谨慎行事？接受静脉注射tPA治疗的患者中神经血管模拟病症的可接受发生率。 - Suppr | 超能文献

Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.

作者信息

Martinez-Ramirez Sergi, Delgado-Mederos Raquel, Martí-Vilalta Josep Lluís, Martí-Fàbregas Joan

出版信息

Neurology. 2010 Nov 16;75(20):1853; author reply 1854. doi: 10.1212/WNL.0b013e3181fac7da.

DOI:10.1212/WNL.0b013e3181fac7da

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.组织型纤溶酶原激活剂（tPA）在疑似中风和神经影像学检查阴性的脑缺血中的安全性：迅速给药还是谨慎行事？接受静脉注射tPA治疗的患者中神经血管模拟病症的可接受发生率。

Neurology. 2010 Nov 16;75(20):1853; author reply 1854. doi: 10.1212/WNL.0b013e3181fac7da.

2

Safety of tPA in stroke mimics and neuroimaging-negative cerebral ischemia: swift or sure? The acceptable rate of neurovascular mimics among IV tPA-treated patients.

Neurology. 2010 Nov 16;75(20):1853-4; author reply 1854.

3

Swift or sure?: The acceptable rate of neurovascular mimics among IV tPA-treated patients.迅速还是确切？：静脉注射组织型纤溶酶原激活剂治疗患者中神经血管模拟物的可接受率。

Neurology. 2010 Apr 27;74(17):1336-7. doi: 10.1212/WNL.0b013e3181dbe0ad. Epub 2010 Mar 24.

4

A model to prevent fibrinolysis in patients with stroke mimics.卒中样发作患者纤维蛋白溶解预防模型。

J Stroke Cerebrovasc Dis. 2012 Nov;21(8):839-43. doi: 10.1016/j.jstrokecerebrovasdis.2011.04.018. Epub 2011 Jun 2.

5

Safety and outcomes in stroke mimics after intravenous tissue plasminogen activator administration: a single-center experience.静脉注射组织型纤溶酶原激活剂后疑似中风患者的安全性及预后：单中心经验

J Stroke Cerebrovasc Dis. 2015 Jan;24(1):48-52. doi: 10.1016/j.jstrokecerebrovasdis.2014.07.048. Epub 2014 Oct 22.

6

Transient ischemic attack after tissue plasminogen activator: aborted stroke or unnecessary stroke therapy?组织型纤溶酶原激活物治疗后发生短暂性脑缺血发作：中止性卒中还是不必要的卒中治疗？

Cerebrovasc Dis. 2010;29(1):57-61. doi: 10.1159/000255975. Epub 2009 Nov 5.

7

Stroke Mimics and Acute Stroke Evaluation: Clinical Differentiation and Complications after Intravenous Tissue Plasminogen Activator.卒中模拟病与急性卒中评估：静脉注射组织型纤溶酶原激活剂后的临床鉴别与并发症

J Emerg Med. 2015 Aug;49(2):244-52. doi: 10.1016/j.jemermed.2014.12.072. Epub 2015 Mar 20.

8

Reducing hemorrhagic complication by dabigatran via neurovascular protection after recanalization with tissue plasminogen activator in ischemic stroke of rat.通过组织型纤溶酶原激活剂再通后达比加群酯的神经血管保护作用降低缺血性脑卒中大鼠的出血性并发症。

J Neurosci Res. 2014 Jan;92(1):46-53. doi: 10.1002/jnr.23302. Epub 2013 Nov 4.

9

Comparison of combined venous and arterial thrombolysis with primary arterial therapy using recombinant tissue plasminogen activator in acute ischemic stroke.急性缺血性卒中中联合静脉和动脉溶栓与使用重组组织型纤溶酶原激活剂进行原发性动脉治疗的比较。

J Stroke Cerebrovasc Dis. 2008 May-Jun;17(3):121-8. doi: 10.1016/j.jstrokecerebrovasdis.2007.12.004.

10

Medicine. Stroke--tPA and the clinic.医学。中风——组织型纤溶酶原激活剂与临床应用

Science. 2003 Sep 19;301(5640):1677. doi: 10.1126/science.1090270.

引用本文的文献

1

Neuroimaging for differential diagnosis of transient neurological attacks.神经影像学在短暂性脑卒中性神经发作鉴别诊断中的应用。

Brain Behav. 2022 Dec;12(12):e2780. doi: 10.1002/brb3.2780. Epub 2022 Nov 9.

2

Stroke Chameleons and Stroke Mimics in the Emergency Department.急诊科中的卒中变色龙与类卒中情况

Curr Neurol Neurosci Rep. 2017 Feb;17(2):15. doi: 10.1007/s11910-017-0727-0.